Pasar al contenido principal

Investigación y educación

Enviado por remote_content el

Diaz A. Quantitative sensory testing: a good tool to identify subclinical neuropathy in ATTRV30M amyloidosis patients? Amyloid.

Investigación y Educación

"Background Quantitative sensory testing (QST) has been one of the neurophysiological tools used for follow-up and disease progression assessment in ATTRv amyloidosis. We aimed to detect the utility of QST in identifying subclinical neuropathic involvement in ATTRV30M amyloidosis carriers.

Conclusions QST, in particular CDT, HP 5 and HP 0.5 modalities, seems a good tool to identify subclinical neuropathy in ATTRv amyloidosis carriers, with CDT showing a higher sensitivity to detect and early neuropathic involvement."

Read full article

Artículos que te pueden interesar

Neurología

"Radiofrequency Treatment of Iliac and Paravertebral Cluneal Nerves for Low Back Pain. Pain Physician."

Octubre 25, 2022

Leer más

Neurología

Structural Protein Effects Underpinning Cognitive Developmental Delay of the PURA p.Phe233del Mutation Modelled by Artificial Intelligence and the Hybrid Quantum Mechanics-Molecular Mechanics Framework. Brain Sci. 2022 Jun

Junio 30, 2022

Leer más

Neurología

"All Bruton's tyrosine kinase inhibitors have similar efficacy and risks: Yes. Mult Scler."

Mayo 2, 2022

Leer más